ARCHIVES

Higher Response For Gleevec In Trial; CML Patients Allowed To Switch

This article is from The Cancer Letter archive.

Vol. 25 No. 1 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

Longterm Followup Finds Taxotere Improves Survival

January 25, 2008

NCI Programs: Researchers Take “Director’s Challenge” to Develop Molecular Profiles of Tumors

December 10, 1999

Mammography For Women Under 50 Debated; Cut Of 3-4% Offered As Budget Trimmer

July 23, 1976

NCCS Networker Volume 2 Issue 4, Fall 1988

September 13, 1988

Court Filing By Fisher; Board, Attacks Interim NSABP Leadership

August 12, 1994

UNC Lineberger Appoints Two, Zaret Wins Chair At Fox Chase.

February 25, 2000